B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice

Blood

Volumn 119, Issue 12, 2012, Pages 2819-2828

  Recher, Mike ^a   Burns, Siobhan O ^b,c   De La Fuente, Miguel A ^a,d   Volpi, Stefano ^a   Dahlberg, Carin ^e   Walter, Jolan E ^a   Moffitt, Kristin ^a   Mathew, Divij ^a   Honke, Nadine ^f   Lang, Philipp A ^f   Patrizi, Laura ^a   Falet, Hervé ^g   Keszei, Marton ^g   Mizui, Masayuki ^g   Csizmadia, Eva ^g   Candotti, Fabio ^h   Nadeau, Kari ⁱ   Bouma, Gerben ^b   Delmonte, Ottavia M ^a   Frugoni, Francesco ^a   Ferraz Fomin, Angela B ^a   Buchbinder, David ^j   Lundequist, Emma Maria ^a   Massaad, Michel J ^a   Tsokos, George C ^g   Hartwig, John ^g   Manis, John ^a   Terhorst, Cox ^g   Geha, Raif S ^a   Snapper, Scott ^g   Lang, Karl S ^f,k   Malley, Richard ^a   Westerberg, Lisa ^e   Thrasher, Adrian J ^b,c   Notarangelo, Luigi D ^a   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY OF VALLADOLID   (Spain)

^e KAROLINSKA INSTITUTE   (Sweden)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g HARVARD MEDICAL SCHOOL   (United States)

^h NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY HOSPITAL ESSEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; WISKOTT ALDRICH SYNDROME PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DENDRITIC CELL; GENE; GENE DELETION; GENE MUTATION; GERMINAL CENTER; HEMATOPOIETIC CELL; HETEROZYGOSITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTE; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; WAS GENE; WISKOTT ALDRICH SYNDROME;

EID: 84858836089     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-379412     Document Type: Article

References (48)

1. Thrasher AJ, Burns SO. WASP: a key immunological multitasker. Nat Rev Immunol. 2010;10(3): 182-192.
2. Meyer-Bahlburg A, Becker-Herman S, Humblet-Baron S, et al. Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood. 2008;112(10):4158-4169.
3. Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9(1):81-91. (Pubitemid 28361297)
4. Facchetti F, Blanzuoli L, Vermi W, et al. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome. J Pathol. 1998;185(1):99-107. (Pubitemid 28266723)
5. Westerberg L, Larsson M, Hardy SJ, Fernandez C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005;105(3):1144-1152. (Pubitemid 40170887)
6. Westerberg LS, de la Fuente MA, Wermeling F, et al. WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. Blood. 2008;112(10):4139-4147.
7. Becker-Herman S, Meyer-Bahlburg A, Schwartz MA, et al.WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med. 2011; 208(10):2033-2042.
8. Hobeika E, Thiemann S, Storch B, et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci U S A. 2006; 103(37):13789-13794.
9. van der Laan LJ, Kangas M, Dopp EA, et al. Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunol Lett. 1997;57(1-3): 203-208.
10. Walter JE, Rucci F, Patrizi L, et al. Expansion of immunoglobulin- secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency. J Exp Med. 2010;207(7):1541-1554.
11. Liberman C, Takagi M, Cabrera-Crespo J, et al. Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium. J Ind Microbiol Biotechnol. 2008;35(11): 1441-1445.
12. Bachmann MF, Bast C, Hengartner H, Zinkernagel RM. Immunogenicity of a viral model vaccine after different inactivation procedures. Med Microbiol Immunol. 1994;183(2):95-104. (Pubitemid 24210544)
13. Lang KS, Navarini AA, Recher M, et al. MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus. Eur J Immunol. 2007;37(9):2434-2440. (Pubitemid 47423614)
14. Li QZ, Zhou J, Wandstrat AE, et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol. 2007;147(1):60-70. (Pubitemid 44915556)
15. Kikawada E, Lenda DM, Kelley VR. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol. 2003; 170(7):3915-3925. (Pubitemid 36359263)
16. Yu F, Wu LH, Tan Y, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int. 2010; 77(9):820-829.
17. Peset Llopis MJ, Harms G, Hardonk MJ, TimensW. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol. 1996;97(4):1015-1024. (Pubitemid 26116997)
18. Ochsenbein AF, Pinschewer DD, Odermatt B, Carroll MC, Hengartner H, Zinkernagel RM. Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med. 1999;190(8):1165-1174. (Pubitemid 29496509)
19. Oehen S, Odermatt B, Karrer U, Hengartner H, Zinkernagel R, Lopez-Macias C. Marginal zone macrophages and immune responses against viruses. J Immunol. 2002;169(3):1453-1458. (Pubitemid 34809190)
20. Forster I, Rajewsky K. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol. 1987;17(4):521-528. (Pubitemid 17094151)
21. Schurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol. 2003;15(4):446-453. (Pubitemid 36774257)
22. Nikolov NP, Shimizu M, Cleland S, et al. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood. 2010;116(5):740-747.
23. Humblet-Baron S, Sather B, Anover S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007; 117(2):407-418. (Pubitemid 46203969)
24. Bouma G, Burns S, Thrasher AJ. Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells. Blood. 2007; 110(13):4278-4284. (Pubitemid 351377792)
25. Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol. 2008; 15(1):30-36. (Pubitemid 350191026)
26. Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009;113(25):6288-6295.
27. Zhang J, Shehabeldin A, da Cruz LA, et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med. 1999;190(9):1329-1342.
28. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA,Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55(2):243-252. (Pubitemid 10161198)
29. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. Amultiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6 pt 1):876-885.
30. Blaese RM, Strober W, Waldmann TA. Immunodeficiency in the Wiskott-Aldrich syndrome. Birth Defects Orig Artic Ser. 1975;11(1):250-254.
31. Simon HU, Mills GB, Hashimoto S, Siminovitch KA. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J Clin Invest. 1992;90(4):1396-1405.
32. Bosticardo M, Draghici E, Schena F, et al. Lentiviralmediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2011;127(6): 1376-1384.
33. Strom TS, Turner SJ, Andreansky S, et al. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood. 2003;102(9):3108-3116. (Pubitemid 37314745)
34. Marangoni F, Bosticardo M, Charrier S, et al. Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. Mol Ther. 2009;17(6):1073-1082.
35. Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol. 2008; 9(1):54-62. (Pubitemid 350286204)
36. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 2002;297(5580):409-412. (Pubitemid 34790772)
37. Girkontaite I, Sakk V, Wagner M, et al. The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization. J Exp Med. 2004;200(11):1491-1501. (Pubitemid 39657296)
38. Tezuka H, Abe Y, Iwata M, et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature. 2007; 448(7156):929-933. (Pubitemid 47312771)
39. Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a singlecenter cohort of 55 patients. Pediatrics. 2003; 111(5 Pt 1):e622-e627.
40. Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004; 103(2):456-464. (Pubitemid 38140073)
41. Maillard MH, Cotta-de-Almeida V, Takeshima F, et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med. 2007;204(2):381-391. (Pubitemid 46294553)
42. Adriani M, Aoki J, Horai R, et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol. 2007;124(1):41-48. (Pubitemid 46936247)
43. Marangoni F, Trifari S, Scaramuzza S, et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med. 2007;204(2):369-380. (Pubitemid 46294552)
44. Bouma G, Mendoza-Naranjo A, Blundell MP, et al. Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T cell priming. Blood. 2011;118(9):2492-2501.
45. Pulecio J, Tagliani E, Scholer A, et al. Expression of Wiskott-Aldrich syndrome protein in dendritic cells regulates synapse formation and activation of naive CD8+ T cells. J Immunol. 2008;181(2): 1135-1142.
46. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell. 2004; 117(2):265-277. (Pubitemid 38496245)
47. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med. 1998; 188(2):387-392. (Pubitemid 28357766)
48. Bygrave AE, Rose KL, Cortes-Hernandez J, et al. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2004;2(8):E243.